Nuo Therapeutics (CMXI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CMXI Annual Balance Sheets →
The table below presents a historical view of Nuo Therapeutics's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Jun 30 2021) (Mar 31 2021) (Dec 31 2020) (Sep 30 2020)
Assets
Cash & cash equivalent0.45
Cash & Short-term Investments0.00
Accounts receivable1.17
Inventories0.27
Prepaid Expense And Other Assets Current0.11
Total Current Assets1.99
Equipment/Property/Plant Net1.14
Tax Assets, Noncurrent0.00
Total Assets2.63
Liabilities
Accounts Payable, Current AC0.56
Accrued Liabilities, Current AC0.62
Notes Payable, Current NO0.00
Other Liabilities, Current0.06
Deferred Revenue, Current DE0.31
Total Current Liabilities1.55
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.86
Other liabilities, Noncurrent1.75
Total Liabilities4.16
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock34.13
Retained Earnings / Accumulated Deficit-35.67
Common Stockholder's Equity-1.54
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-1.54
Liabilities & Stockholder's Equity2.63
4 historic quarters locked

Sign in to unlock the full Nuo Therapeutics balance sheet history.

About Nuo Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-028053

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.